Karthik Kuppusamy sold $1.8M of DGX
SVP, Clinical Solutions at QUEST DIAGNOSTICS INC. 10,479 shares at an average of $167.95, traded Jul 30, 2025, filed Aug 1, 2025.
Score components
- +15RoleOfficer
- +25Trade size$1.8M at market
- +20Share of holdings soldSold 76% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +6.3%, 3m +3.4%, 6m +10.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001022079-25-000195, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 30, 2025 | MOption exercise Common Stock10b5-1 | +3,045 | $86.63 | $264k | 13,705 | Aug 1, 2025 |
| Jul 30, 2025 | SOpen-market sale Common Stock10b5-1 | -3,045 | $167.40 | $510k | 10,660 | Aug 1, 2025 |
| Jul 30, 2025 | MOption exercise Common Stock10b5-1 | +5,224 | $112.17 | $586k | 15,884 | Aug 1, 2025 |
| Jul 30, 2025 | SOpen-market sale Common Stock10b5-1 | -5,224 | $167.40 | $874k | 10,660 | Aug 1, 2025 |
| Jul 31, 2025 | SOpen-market sale Common Stock10b5-1 | -2,210 | $170.00 | $376k | 8,450 | Aug 1, 2025 |
| Jul 30, 2025 | MOption exercise Non-Qualifed Stock Option (right to buy)derivative10b5-1 | -3,045 | $86.63 | $264k | 0 | Aug 1, 2025 |
| Jul 30, 2025 | MOption exercise Non-Qualifed Stock Option (right to buy)derivative10b5-1 | -5,224 | $112.17 | $586k | 0 | Aug 1, 2025 |
Related signals
Other insiders at QUEST DIAGNOSTICS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 38Weak | QUEST DIAGNOSTICS INC | J. E. Davis CEO and President | $2.4M 10,000 shares | -8% | |
| 23Weak | QUEST DIAGNOSTICS INC | Michael E Prevoznik SVP & General Counsel | $5.5M 22,677 shares | -38% | |
| 16Weak | QUEST DIAGNOSTICS INC | Mark E Delaney SVP & Chief Commercial Officer | $376k 1,600 shares | -13% | |
| 23Weak | QUEST DIAGNOSTICS INC | Karthik Kuppusamy SVP, Clinical Solutions | $1.6M 8,147 shares | -38% | |
| 38Weak | QUEST DIAGNOSTICS INC | J. E. Davis CEO and President | $1.9M 10,000 shares | -7% | |
| 35Weak | QUEST DIAGNOSTICS INC | Catherine T. Doherty EVP, Regional Businesses | $1.1M 5,558 shares | -8% | |
| 54Moderate | QUEST DIAGNOSTICS INC | Karthik Kuppusamy SVP, Clinical Solutions | $538k 2,628 shares | -16% | |
| 32Weak | QUEST DIAGNOSTICS INC | Michael E Prevoznik SVP & General Counsel | $800k 3,878 shares | -9% | |
| 34Weak | QUEST DIAGNOSTICS INC | Patrick Plewman SVP for Diagnostic Services | $589k 2,855 shares | -16% | |
| 45Moderate | QUEST DIAGNOSTICS INC | J. E. Davis CEO and President | $2.1M 10,000 shares | -8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.